NOD Publications

NOD Model Page

Filter publications by application: All Behavior Diabetes (Type 1) T And/Or B Cell Function
Filter publications by model type: All

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Washburn LR, et al.
Mouse over for full list
Washburn LR, Dang H, Tian J, Kaufman DL
(2007) The postnatal maternal environment influences diabetes development in nonobese diabetic mice. J. Autoimmun. 28(1):19-23
Tracy S, et al.
Mouse over for full list
Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS
(2002) Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76(23):12097-111
Tian C, et al.
Mouse over for full list
Tian C, Bagley J, Cretin N, Seth N, Wucherpfennig KW, Iacomini J
(2004) Prevention of type 1 diabetes by gene therapy. J. Clin. Invest. 114(7):969-78
Diabetes (Type 1)
Swyers J
Mouse over for full list
Swyers J
(2007) Antibody therapy prevents type 1 diabetes in mice
Ryu S, et al.
Mouse over for full list
Ryu S, Kodama S, Ryu K, Schoenfeld DA, Faustman DL
(2001) Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J. Clin. Invest. 108(1):63-72
Mabley JG, et al.
Mouse over for full list
Mabley JG, Rabinovitch A, Suarez-Pinzon W, Haskó G, Pacher P, Power R, Southan G, Salzman A, Szabó C
(2003) Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes. Mol. Med. 9(3-4):96-104
Diabetes (Type 1)
Liu E, et al.
Mouse over for full list
Liu E, Moriyama H, Abiru N, Miao D, Yu L, Taylor RM, Finkelman FD, Eisenbarth GS
(2002) Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J. Clin. Invest. 110(7):1021-7
Irie J, et al.
Mouse over for full list
Irie J, Wu Y, Kachapati K, Mittler RS, Ridgway WM
(2007) Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes. Diabetes 56(1):186-96
Diabetes (Type 1)
Homo-Delarche F
Mouse over for full list
Homo-Delarche F
(2004) Neuroendocrine immuno-ontogeny of the pathogenesis of autoimmune disease in the nonobese diabetic (NOD) mouse. ILAR J 45(3):237-58
Goudy K, et al.
Mouse over for full list
Goudy K, Song S, Wasserfall C, Zhang YC, Kapturczak M, Muir A, Powers M, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Ellis TM, Flotte TR, Atkinson MA
(2001) Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc. Natl. Acad. Sci. U.S.A. 98(24):13913-8
Diabetes (Type 1)
Gordon EJ, et al.
Mouse over for full list
Gordon EJ, Wicker LS, Peterson LB, Serreze DV, Markees TG, Shultz LD, Rossini AA, Greiner DL, Mordes JP
(2005) Autoimmune diabetes and resistance to xenograft transplantation tolerance in NOD mice. Diabetes 54(1):107-15
Fife BT, et al.
Mouse over for full list
Fife BT, Griffin MD, Abbas AK, Locksley RM, Bluestone JA
(2006) Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. J. Clin. Invest. 116(8):2252-61
T And/Or B Cell Function
da Costa SR, et al.
Mouse over for full list
da Costa SR, Wu K, Veigh MM, Pidgeon M, Ding C, Schechter JE, Hamm-Alvarez SF
(2006) Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development. Exp. Eye Res. 82(1):33-45
Bour-Jordan H, et al.
Mouse over for full list
Bour-Jordan H, Salomon BL, Thompson HL, Szot GL, Bernhard MR, Bluestone JA
(2004) Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J. Clin. Invest. 114(7):979-87
Bergerot I, et al.
Mouse over for full list
Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, Lindblad M, Mayer A, Czerkinsky C, Holmgren J, Thivolet C
(1997) A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. U.S.A. 94(9):4610-4
Basso AS, et al.
Mouse over for full list
Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M, Weiner HL
(2008) Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J. Clin. Invest. 118(4):1532-43
Atkinson MA, et al.
Mouse over for full list
Atkinson MA, Leiter EH
(1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5(6):601-4
Diabetes (Type 1)
Bothe GW, et al.
Mouse over for full list
Bothe GW, Bolivar VJ, Vedder MJ, Geistfeld JG
(2005) Behavioral differences among fourteen inbred mouse strains commonly used as disease models. Comp. Med. 55(4):326-34
Behavior